Andipal, tablets No. 10

General characteristics. Structure:

Active agents: analginum (metamizole sodium) - 0,25 g, phenobarbital of-0,02 g; Dibazolum (Bendazolum) - 0,02 g, a papaverine a hydrochloride - 0,02 g.
Excipients: potato starch, talc, stearic acid, calcium stearate.

Description: Tablets of color, white or white with a weak yellow shade, ploskotsilindrichesky with a facet and risky.

Pharmacological properties:

The combined drug. The combination of components of drug leads to mutual strengthening of their pharmacological action.
Metamizole sodium - derivative pyrazyl ketone, has analgeziruyushchy and febrifugal effect.
Bendazolum (Dibazolum) - vazodilatiruyushchy means; possesses vasodilating action, stimulates function of a spinal cord. Has direct spasmolytic effect on unstriated muscles of blood vessels and internals. Facilitates synoptic transfer in a spinal cord.
Papaverine a hydrochloride - the antispasmodic, has hypotensive effect, reduces a tone and weakens unstriated muscles of internals and vessels.
Phenobarbital, in small doses renders sedation and strengthens action of other components.

Indications to use:

Pain syndrome (poorly or moderately expressed) at spasms of smooth muscles of internals: renal colic, bilious colic, intestinal colic; dyskinesia of biliary tract, postcholecystectomy syndrome; spasm of ureters and bladder; альгодисменорея.
Brain vasospasm, migraine.
As auxiliary medicine: a pain syndrome after surgical intervention and diagnostic procedures.

Route of administration and doses:

Inside, to adults and children 8 years on 1 tablet 2-3 times a day are more senior.
Use duration without consultation of the doctor should not exceed 7 days.

Features of use:

At long (more than 7 days) use control of a picture of peripheral blood and a functional condition of a liver is necessary.
In the absence of effect within 3 days it is necessary to stop administration of drug and to see a doctor.
During treatment it is necessary to refuse occupations potentially dangerous types of activity demanding the increased concentration of attention and speed of psychomotor reactions.
Children and teenagers up to 18 years should use drug only on doctor's orders.

Side effects:

Allergic reactions.
From the central nervous system: drowsiness, reduction in the rate of psychomotor reactions.
From digestive tract: nausea, lock.
From cardiovascular system: arterial hypotension.
At prolonged use: leukopenia, agranulocytosis, abnormal liver function and
kidneys.

Contraindications:

Hypersensitivity (including to pyrazyl ketone derivatives); oppression of a marrowy hemopoiesis; the expressed liver and/or renal failure; deficit glyukozo-6-fosfatdegidrogenazy; children are younger than 8 years, pregnancy, the period of a lactation, tachyarrhythmia, heavy stenocardia, a collapse, dekompensirovanny chronic heart failure; closed-angle glaucoma; prostate hyperplasia; intestinal impassability, megacolon.

Storage conditions:

Period of validity: 2 years 6 months. Drug cannot be used after expiry date. In dry, protected from light and the place, unavailable to children.

Issue conditions:

Without recipe

Packaging:

On 10 tablets in planimetric strip or bezjyacheykovy packaging; 2 blister strip packagings in a pack cardboard with the instruction on a medical use, place planimetric bezjyacheykovy packagings with the equal number of instructions on a medical use in group packaging.